Publisher: Bentham Science Publishers
ISSN: 2213-476X
Source: Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol.1, Iss.1, 2014-04, pp. : 28-36
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drug price cuts in Japan affect big pharma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 356, 2002-01 ,pp. :
Big pharma in the spotlight over offshore trials
Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. :
Conflict-of-interest policies protect docs from big pharma influence
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. :
The Big Three of US Pharma: Pfizer, Merck & Co. and GlaxoSmithKline
Pharmaceutical Innovation, Vol. 11, Iss. 5, 2002-08 ,pp. :
Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department
Current Drug Metabolism, Vol. 17, Iss. 3, 2016-03 ,pp. :